Compound details
Zhebeininoside
| Compound ID | CDAMM01192 |
|---|---|
| Common name | Zhebeininoside | IUPAC name | 2-[(10,17-dihydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.02,11.04,9.015,24.018,23]pentacosan-20-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| Molecular formula | C33H55NO8 |
| Retention time | 16.87 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 594.404 | Theoretical mz | 594.4 |
| Error | 6.27 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.6537 |
| Inchi key | HRUKKZDXKJUOSO-UHFFFAOYNA-N |
|---|---|
| Smiles | OCC1OC(OC2CCC3(C)C(C2)C(O)CC4C5CCC6C(CN7CC(C)CCC7C6(O)C)C5CC43)C(O)C(O)C1O |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T18639 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | P05230 | FGF1 |
| T18639 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P05230 | FGF1 |
| T31621 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P09038 | FGF2 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |